CVSG.GB CVS Group Plc

TIDMCVSG

RNS Number : 5744Y

CVS Group plc

05 May 2023

5 May 2023

CVS Group plc

("CVS" or the "Company")

Block Listing Application

CVS, one of the UK's leading providers of integrated veterinary services, announces that an application has been made to the Financial Conduct Authority and the London Stock Exchange for the admission of 120,000 of its ordinary shares of 0.2p each in the Company ("Ordinary Shares") to trading on AIM.

The Ordinary Shares will be reserved under a block listing and will be issued in connection with the grant, vesting and/or exercise of awards under the terms of the Company's Long Term Incentive Plans ("LTIP"). It is expected that the majority of the shares reserved under the block listing will satisfy the exercise of options in connection with the next LTIP vesting on 2 October 2023.

When issued, the Ordinary Shares under the block listing will rank pari passu with the Company's existing issued Ordinary Shares. It is anticipated that the block-listed shares will be admitted on 11 May 2023.

Contacts:

CVS Group plc via Camarco

Richard Fairman, CEO

Jenny Farrer, Company Secretary

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell +44 (0)7789 151 644

About CVS Group plc ( www.cvsukltd.co.uk )

CVS Group is an AIM-quoted fully-integrated provider of veterinary services in the UK, with practices in the Netherlands and the Republic of Ireland. CVS is focused on providing high quality clinical services to its customers and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group has c.500 veterinary practices across its three markets, including eight specialist referral hospitals and 37 dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices), Buying Groups and the Group's online retail business ("Animed Direct").

The Group employs c.8,500 personnel, including c.2,200 veterinary surgeons and c.3,100 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ALSUPUGAAUPWUMA

(END) Dow Jones Newswires

May 05, 2023 03:53 ET (07:53 GMT)

CVS (AQSE:CVSG.GB)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024

CVS (AQSE:CVSG.GB)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024